Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 12:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Burn Injury
Interventions: coenzyme Q10, Placebo; Dietary Supplement
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Left Ventricular Dysfunction, Ventricular Dysfunction, Heart Diseases, Cardiovascular Diseases
Interventions: Use of Eko DUO Electronic Stethoscope; Device
Lead sponsor: Eko Devices, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,935 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: O'Fallon, Illinois • Springfield, Illinois

Conditions: Cognitive Decline, Dementia, Vascular, Alzheimer Disease, Dementia, Stroke
Interventions: Behavioral Dietary intervention ( MIND Diet), Behavioral Usual Care Diet Intervention; Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: 55 Years and older
Enrollment: 266 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cognition Disorders in Old Age, Mild Cognitive Impairment, Cognitive Decline
Interventions: Niagen, Placebo Comparator; Dietary Supplement
Lead sponsor: Steven E Arnold, MD; Other
Eligibility: 60 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Voiding Dysfunction
Interventions: Not listed
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Delayed Ejaculation
Interventions: TENS penile nerve stimulation; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Mild Cognitive Impairment
Interventions: Alpha-lactalbumin, Whey, Casein; Dietary Supplement
Lead sponsor: Texas A&M University; Other
Eligibility: 55 Years and older
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: College Station, Texas

Conditions: Septic Shock, Inflammation, Glucose Homeostasis, Organ Dysfunction, Health-related Quality of Life
Interventions: Exenatide, Exenatide vehicle; Drug
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 1 Month to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Neurologic Disorders, Nervous System Diseases, Neurodegenerative Diseases, Neurological Disorders, Stroke, Traumatic Brain Injury, Cadasil, Chronic Traumatic Encephalopathy, Cerebral Infarction, Cerebral Ischemia, Cerebral Stroke, Cerebral Hemorrhage, Parkinson, Multi-System Degeneration, MSA - Multiple System Atrophy, Progressive Supranuclear Palsy, ALS, Amyotrophic Lateral Sclerosis, Neuropathy, Diabetic Neuropathies, Alzheimer Disease, Dementia, Frontotemporal Dementia, Lewy Body Disease, Cognitive Impairment, Lewy Body Variant of Alzheimer Disease
Interventions: Intravenous and Intranasal BMSC; Procedure
Lead sponsor: MD Stem Cells; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2028
U.S. locations: 2
States / cities: Westport, Connecticut • Coral Springs, Florida

Conditions: Hot Weather; Adverse Effect, Kidney Dysfunction, Kidney Injury, Hyperthermia, Dehydration
Interventions: 23.0°C WBGT - Fixed Work Rate, 25.5°C WBGT - Fixed Work Rate, 27.5°C WBGT - Fixed Work Rate, 28.5°C WBGT - Fixed Work Rate, 35.5°C WBGT - Fixed Work Rate, 26.0°C WBGT - Fixed work-to-rest ratio, 30.5°C WBGT - Fixed work-to-rest ratio, 30.5°C WBGT - Fixed work-to-rest ratio (high intensity); Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 44 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Cancer, Urinary Obstruction, Malignancy, Urinary Dysfunction, Ureter Obstruction, Ureter Injury
Interventions: Ureteral Stent, Percutaneous Nephrostomy Tube Placement; Device
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Temporomandibular Joint Dysfunction Syndrome
Interventions: PACT Experimental Arm; Behavioral
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Diabetes Insipidus, Diabetes Insipidus, Neurohypophyseal
Interventions: chlorpropamide, desmopressin; Drug
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 6 Months to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1995
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Multiple Sclerosis, Cognitive Decline
Interventions: Computerized gaming rehabilitation Program 1, Computerized gaming rehabilitation Program 2; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 60 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Dry Eye, Meibomian Gland Dysfunction
Interventions: TearCare System, Cyclosporine Ophthalmic 0.05% Ophthalmic Emulsion; Device · Drug
Lead sponsor: Sight Sciences, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 345 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 14
States / cities: Scottsdale, Arizona • La Jolla, California • Laguna Hills, California + 11 more

Conditions: Alzheimer Disease (AD), Cardio Vascular Disease, Mild Cognitive Impairment (MCI), Frailty Syndrome, Disability Physical, Hypertension, Metabolic Syndrome (MetS), Healthy Aging, Obesity &Amp; Overweight
Interventions: Not listed
Lead sponsor: Marymount University; Other
Eligibility: 50 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Arlington, Virginia

Conditions: HIV Infections, Lipodystrophy, Insulin Resistance
Interventions: Avandia administration for 6-12 weeks; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 55 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2003
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Chronic Granulomatous Disease, Infection
Interventions: gp91 Grans; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 75 Years · Male only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Spinal Cord Injuries, Endothelial Dysfunction, Testosterone Deficiency
Interventions: Intra-arterial Infusion of Vasoactive Agents, Intra-arterial Vitamin C Infusion, Blood Sampling; Diagnostic Test
Lead sponsor: Craig Hospital; Other
Eligibility: 18 Years to 89 Years · Male only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Mild Cognitive Impairment, So Stated, Cocaine Use Disorder
Interventions: Occupational therapy-based cognitive rehabilitation, Psychoeducation/games; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Heart; Dysfunction Postoperative, Cardiac Surgery
Interventions: Ranolazine, Placebo; Drug
Lead sponsor: Corewell Health East; Other
Eligibility: 22 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Royal Oak, Michigan • Troy, Michigan

Conditions: Multiple Sclerosis, Gait Disorders, Neurologic, Motility Disorder, Cognitive Impairment
Interventions: Robotic Exoskeleton Rehabilitation, Conventional Gait Therapy; Device · Other
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Campylobacter Infections, Irritable Bowel Syndrome
Interventions: DNA Analysis of Blood Sample, Flexible sigmoidoscopy with colonic biopsies, Small bowel and colonic gastrointestinal permeability, Stool sample analysis; Genetic · Procedure · Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cognitive Impairment, Progressive, Cerebral Small Vessel Diseases
Interventions: High-Speed Circuit Resistance Training, Lecture on Diet, Exercise and Cognition; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 65 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Coral Gables, Florida

Search by objective public record fields.

Assessing Bioavailability of CoQ10 Supplementation in Burn Patients

Low Ejection Fraction in Single Lead ECG

Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients

Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment

Voiding Dysfunction in the Postoperative Period Following Placement of the TVT

Penile Nerve Stimulation for Treatment of Delayed Ejaculation

Effects of Alpha-lactalbumin Intake on Metabolic and Cognitive Functions in Elderly

Pharmacology of Exenatide in Pediatric Sepsis

Neurologic Stem Cell Treatment Study

Renal Considerations in the Heat Stress Recommendations

Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent

Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology

Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus

Computerized Cognitive Training in MS

Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)

Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)

Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome

NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)

Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury

Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study

Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery

Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders

Circuit Training and Retina